PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER
Clinical trials for PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: targeted drug MBRC-201 enters human trials
Disease control Recruiting nowThis study tests a new drug called MBRC-201 in people with advanced solid tumors (like prostate, breast, lung, colorectal, or pancreatic cancer) that have not responded to standard treatments. The goal is to find the best dose and see if it can shrink tumors or slow their growth.…
Matched conditions: PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: MBrace Therapeutics • Aim: Disease control
Last updated May 17, 2026 04:35 UTC
-
Engineered immune cells take on Hard-to-Treat prostate cancer
Disease control Recruiting nowThis early-phase study tests a new cell therapy called Anti-PSMA CAR NK cells in 10 men with metastatic castration-resistant prostate cancer (mCRPC) that has stopped responding to hormone therapy. The treatment uses modified immune cells to target a protein (PSMA) on cancer cells…
Matched conditions: PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 17, 2026 04:17 UTC
-
Engineered immune cells take on Hard-to-Treat prostate cancer
Disease control Recruiting nowThis early-stage study tests a new treatment for men with metastatic castration-resistant prostate cancer, a form that no longer responds to standard hormone therapy. The treatment uses specially engineered natural killer (NK) cells from healthy donors to target and kill cancer c…
Matched conditions: PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 15, 2026 11:54 UTC